Skip to main content
Caplight Logo









Elicityl

Elicityl

Private
CrollesHealthcare & Life Scienceshttps://www.elicityl-oligotech.com/

Last Round

VC Round

Sep 27, 2015

Company Overview

Elicityl is a biotechnology company that specializes in the design, manufacturing, and supply of bioactive oligosaccharides, polysaccharides, and glycoconjugates for applications in human health, animal nutrition, and plant health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

oligosaccharidespolysaccharidesglycobiologyglycansbiotechnologycontract research organizationCRObiomolecule purificationbacterial fermentationbiocontrolphytopharmaceuticalcustom synthesisresearch reagentsglycochemistrysugar chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elicityl Comparables

Compare Elicityl with similar companies based on industry and business-model similarity.

Elicityl comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sussex Research Laboratories Inc.
84%
zuChem, Inc.
84%
ICE Pharma
79%

Elicityl Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 27, 2015

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Monthly visitors grew 69% MoM, reaching 3.9K.

  • Apr 13, 2025

    Monthly visitors grew 353% MoM, reaching 1.8K.

Elicityl Filings

Explore SEC and related filing metadata, where available.

Elicityl filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Elicityl's valuation, stock price, and market status.

Is Elicityl a public or private company?

Elicityl is a private company.

What is the current stock price of Elicityl?

Elicityl is a private company with no public stock price. No recent secondary market data is available.

How much is Elicityl worth (valuation)?

Valuation information for Elicityl is not publicly available.

Can I buy Elicityl stock?

Elicityl shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Elicityl's last funding round?

Elicityl's most recent funding round was VC Round on September 27, 2015.

Who are the main investors in Elicityl?

Investor information for Elicityl is not publicly disclosed.

Will Elicityl IPO soon?

No public IPO plans have been announced for Elicityl.

How can I track Elicityl secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elicityl's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCrolles
Employee Range13
Year Founded2002
Last FundingSep 27, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?